Marvell Technology
(MRVL) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this chipmaker have returned -24%, compared to the Zacks S&P 500 composite’s -4.4% change. During this period, the Zacks Technology Services industry, which Marvell falls in, has lost 4.3%. The key question now is: What could be the stock’s future direction?
While media releases or rumors about a substantial change in a company’s business prospects usually make its stock ‘trending’ and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Earnings Estimate Revisions
Here at Zacks, we prioritize appraising the change in the projection of a company’s future earnings over anything else. That’s because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors’ interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For the current quarter, Marvell is expected to post earnings of $0.46 per share, indicating a change of -8% from the year-ago quarter. The Zacks Consensus Estimate has changed -32% over the last 30 days.
The consensus earnings estimate of $2.12 for the current fiscal year indicates a year-over-year change of +35%. This estimate has changed -9.1% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $2.01 indicates a change of -5.2% from what Marvell is expected to report a year ago. Over the past month, the estimate has changed -23.6%.
Having a strong
externally audited track record
, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock’s price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other
factors related to earnings estimates
, Marvell is rated Zacks Rank #5 (Strong Sell).
The chart below shows the evolution of the company’s forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth Forecast
Even though a company’s earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It’s almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company’s potential revenue growth is crucial.
For Marvell, the consensus sales estimate for the current quarter of $1.4 billion indicates a year-over-year change of +4.3%. For the current and next fiscal years, $5.9 billion and $6.02 billion estimates indicate +32.2% and +2% changes, respectively.
Last Reported Results and Surprise History
Marvell reported revenues of $1.54 billion in the last reported quarter, representing a year-over-year change of +26.9%. EPS of $0.57 for the same period compares with $0.43 a year ago.
Compared to the Zacks Consensus Estimate of $1.56 billion, the reported revenues represent a surprise of -1.33%. The EPS surprise was -3.39%.
Over the last four quarters, Marvell surpassed consensus EPS estimates three times. The company topped consensus revenue estimates three times over this period.
Valuation
No investment decision can be efficient without considering a stock’s valuation. Whether a stock’s current price rightly reflects the intrinsic value of the underlying business and the company’s growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company’s valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock’s price.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Marvell is graded D on this front, indicating that it is trading at a premium to its peers.
Click here
to see the values of some of the valuation metrics that have driven this grade.
Conclusion
The facts discussed here and much other information on Zacks.com might help determine whether or not it’s worthwhile paying attention to the market buzz about Marvell. However, its Zacks Rank #5 does suggest that it may underperform the broader market in the near term.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
